GEN vs BBIO

Comparison between Gen Digital Inc (GEN, Company) and BridgeBio Pharma Inc (BBIO, Company).

GEN is from the Technology sector, while BBIO is from the Healthcare sector.

5-Year PerformanceBBIO has outperformed GEN, delivering a return of +9.2% compared to +5.3%

GEN vs BBIO - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	GEN(COMPANY)	BBIO(COMPANY)
Market Cap	$17B	$16B
Max Drawdown	69.98%	92.80%
Sharpe Ratio	0.07	1.30
5Y Beta	0.86	1.02
Industry	Software - Infrastructure	Biotechnology
P/E Ratio	17.17	-22.15
Forward P/E	9.30	N/A
PEG Ratio	0.32	-3.95
Dividend Yield	1.77%	N/A
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	11.22%	-3.14%
Debt to Equity	313.90%	-116.44%
Free Cash Flow Yield	9.22%	-2.72%
P/S Ratio	3.27	28.21
P/B Ratio	6.34	123.68

Market Cap

Winner

GEN

$17B

BBIO

$16B

Max Drawdown

Winner

GEN

69.98%

BBIO

92.80%

Sharpe Ratio

GEN

0.07

Winner

BBIO

1.30

5Y Beta

Winner

GEN

0.86

BBIO

1.02

Industry

GEN

Software - Infrastructure

BBIO

Biotechnology

P/E Ratio

GEN

17.17

Winner

BBIO

-22.15

Forward P/E

GEN

9.30

BBIO

N/A

PEG Ratio

GEN

0.32

Winner

BBIO

-3.95

Dividend Yield

GEN

1.77%

BBIO

N/A

5Y Dividends CAGR

GEN

4.56%

BBIO

N/A

5Y EPS CAGR

Winner

GEN

11.22%

BBIO

-3.14%

Debt to Equity

GEN

313.90%

Winner

BBIO

-116.44%

Free Cash Flow Yield

Winner

GEN

9.22%

BBIO

-2.72%

P/S Ratio

Winner

GEN

3.27

BBIO

28.21

P/B Ratio

Winner

GEN

6.34

BBIO

123.68

GEN vs BBIO - Historical Returns

Returns include dividend reinvestment.

Period	GEN	BBIO
1 month	+6.00%	+6.32%
3 months	+44.75%	+18.96%
6 months	+24.57%	+9.15%
1 year	-0.57%	+71.87%
5 years(CAGR)	+5.30%	+9.21%
10 years(CAGR)	+10.64%	N/A
Max(CAGR)	+10.07%	+16.61%

GEN

+6.00%

Winner

BBIO

+6.32%

Winner

GEN

+44.75%

BBIO

+18.96%

Winner

GEN

+24.57%

BBIO

+9.15%

GEN

-0.57%

Winner

BBIO

+71.87%

5Y(CAGR)

GEN

+5.30%

Winner

BBIO

+9.21%

10Y(CAGR)

GEN

+10.64%

BBIO

N/A

Max(CAGR)

GEN

+10.07%

Winner

BBIO

+16.61%

GEN vs BBIO - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	GEN	BBIO
2026	+9.57%	+4.90%
2025	+0.70%	+171.24%
2024	+22.56%	-32.16%
2023	+8.30%	+463.04%
2022	-16.94%	-55.59%
2021	+27.65%	-73.79%
2020	+39.08%	+114.06%
2019	+36.84%	+27.22%
2018	-33.76%	N/A
2017	+18.10%	N/A
2016	+44.85%	N/A
2015	-15.67%	N/A
2014	+12.28%	N/A
2013	+23.24%	N/A
2012	+19.26%	N/A
2011	-8.80%	N/A
2010	-9.02%	N/A
2009	+20.88%	N/A
2008	-15.82%	N/A
2007	-24.37%	N/A
2006	+19.21%	N/A
2005	-33.21%	N/A
2004	+48.30%	N/A
2003	+61.67%	N/A
2002	+20.73%	N/A
2001	+97.65%	N/A
2000	-41.32%	N/A
1999	+22.45%	N/A

GEN vs BBIO Drawdown Comparison

The maximum drawdown for GEN was -69.98%, occurring on Nov 20, 2008. Recovery took 2959 trading sessions.

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The current GEN drawdown is -10.40%. The current BBIO drawdown is -8.98%.

Rank	GEN	BBIO
#1	-69.98% Dec 3, 2004 - Sep 6, 2016	-92.80% Feb 8, 2021 - Dec 3, 2025
#2	-63.11% Mar 10, 2000 - Mar 4, 2002	-65.45% Dec 23, 2019 - Nov 24, 2020
#3	-48.41% Feb 9, 2022 - Oct 31, 2024	-44.53% Sep 3, 2019 - Nov 20, 2019
#4	-47.58% Sep 19, 2017 - Feb 7, 2020	-21.99% Dec 31, 2020 - Feb 8, 2021
#5	-43.59% Aug 13, 2025 - Apr 10, 2026	-20.25% Jan 22, 2026 - Jul 9, 2026
#6	-34.74% Mar 19, 2002 - Nov 15, 2002	-16.79% Nov 22, 2019 - Dec 9, 2019
#7	-27.66% Dec 22, 1999 - Feb 10, 2000	-14.67% Jul 22, 2019 - Aug 26, 2019
#8	-25.53% Dec 4, 2024 - Aug 12, 2025	-12.87% Jul 11, 2019 - Jul 22, 2019
#9	-24.68% Aug 26, 2020 - May 12, 2021	-11.32% Jul 9, 2026 - Aug 3, 2026
#10	-21.43% Feb 25, 2003 - Jun 6, 2003	-6.70% Dec 12, 2019 - Dec 18, 2019
#11	-19.76% Feb 20, 2020 - Apr 24, 2020	-6.15% Jan 2, 2026 - Jan 13, 2026
#12	-18.93% Apr 22, 2004 - Sep 10, 2004	-5.62% Jul 5, 2019 - Jul 11, 2019
#13	-16.90% May 10, 2017 - Sep 12, 2017	-5.28% Aug 27, 2019 - Sep 3, 2019
#14	-16.67% Jun 10, 2021 - Feb 8, 2022	-4.46% Dec 1, 2020 - Dec 4, 2020
#15	-15.57% May 29, 2020 - Aug 7, 2020	-4.45% Dec 18, 2019 - Dec 20, 2019